Deudextromethorphan/quinidine
Deudextromethorphan/quinidine is a combination medication used in the treatment of Pseudobulbar Affect (PBA). This condition is characterized by uncontrollable, inappropriate laughing or crying, often seen in people with certain neurological conditions or injuries. The medication combines two active ingredients: deudextromethorphan and quinidine.
Composition
The medication is composed of two active ingredients: Deudextromethorphan and Quinidine. Deudextromethorphan is a NMDA receptor antagonist and sigma-1 receptor agonist, and it is the active ingredient responsible for the therapeutic effect of the medication. Quinidine, on the other hand, is a class I antiarrhythmic agent that serves to increase the bioavailability of deudextromethorphan through inhibition of the CYP2D6 enzyme.
Mechanism of Action
The exact mechanism of action of deudextromethorphan/quinidine in the treatment of PBA is not fully understood. However, it is believed that deudextromethorphan's antagonism of NMDA receptors and agonism of sigma-1 receptors in the brain play a key role. Quinidine increases the concentration of deudextromethorphan by inhibiting its metabolism by the CYP2D6 enzyme.
Indications
Deudextromethorphan/quinidine is indicated for the treatment of PBA. It is not intended for other types of emotional lability that can occur in individuals with neurological conditions or injuries.
Side Effects
Common side effects of deudextromethorphan/quinidine include dizziness, diarrhea, cough, vomiting, asthenia, peripheral edema, urinary tract infections, influenza, increased gamma-glutamyltransferase, and flatulence. Serious side effects may include thrombocytopenia and hepatitis.
Contraindications
Deudextromethorphan/quinidine is contraindicated in individuals with a history of quinidine, quinine, or mefloquine-induced thrombocytopenia, hepatitis, bone marrow depression, or lupus-like syndrome. It is also contraindicated in individuals who are hypersensitive to dextromethorphan.
Interactions
Deudextromethorphan/quinidine can interact with a number of other medications, including monoamine oxidase inhibitors (MAOIs), quinidine, quinine, mefloquine, SSRIs, and tricyclic antidepressants.
See Also
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
